Our results pointed out women with obesity, hypertension, higher levels of chronic inflammation (particularly increased hsCRP or SAA) and impaired preoperative LV EF as the patients at the highest postoperative risk, suggesting that this group needs stricter CV risk control and may benefit from integrated cardiological follow-up after surgery. The gene discussed is SAA2; the disease is Obesity.